Fintiv-based PTAB decision faces scrutiny from Vidal
USPTO director’s decision to step in puts more spotlight on controversial rule | Vidal uses remit granted by US v Arthrex.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Patents
23 November 2022 Kathi Vidal’s explosive intervention in OpenSky v VLSI saw dormant concerns over the director review process resurface. Did she go too far, will she change tack, and what might a new-look process look like? Muireann Bolger speaks to lawyers from Wilson Sonsini Goodrich & Rosati, Haynes Boone, and Finnegan to find out more.
Patents
8 December 2022 With the addition of USPTO director reviews and some key cases, the Patent Trial and Appeal Board has once again had a remarkable year, finds Muireann Bolger.
Patents
18 October 2022 USPTO director agrees to consider the Board's decision, citing the ‘unusual and complex nature’ of the case | Vidal announces review after sanctioning OpenSky for alleged IPR abuse.